Phenominer Database Results (1652 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Average Type Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
BN/Crl body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass male 168 days 15 313.0 g 4.0 15.49 body weighing method 0 11292 66
BN/Crl body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass female 84 days 33 160.0 g 2.0 11.49 body weighing method 0 11295 66
BN.GK-(D2Wox30-D2Wox68)/Ox body weight control condition Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. body mass female 90 days 17 174.0 g 4.0 16.49 body weighing method 0 11305 69
SS/JrSeac body weight control condition Fukushima K, et al., Nucl Med Biol. 2010 Nov;37(8):1005-12. Epub 2010 Sep 1. body mass not specified 42 days 20 195.0 g 3.35 15.0 body weighing method 0.0 0 67247 733
BN.GH-(D6Mit12-D6Rat15)/Mcwi body weight angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. body mass male 132 days-146 days 16 299.9 g 6.0 24.0 body weighing method 0 11541 101
F344/NSlc body weight specific pathogen-free condition then fasting (for 16 hours) Fuse M, et al., Physiol Genomics. 2008 Jul 8;. body mass male 420 days 7 470.3 g 9.59 25.37 body weighing method 0 0 11607 106
WKY/NHsd body weight fasting (for 16 hours) Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 body mass male 119 days 10 352.0 g 4.5 14.23 body weighing method 0 0 11608 107
SS.LEW-(D5Mit9-D5Mco10)/Jr body weight controlled sodium content diet (2 %) (between 24 and 27 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass not specified 64 days-71 days 40 282.0 g 1.8 11.38 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 64717 222
SS.SR-(D7Mco7-D7Wox19)/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. body mass male 68 days-70 days 20 299.4 g 2.8 12.52 body weighing method 0 11824 147
SS/Jr body weight controlled sodium content diet (0.2 %) (for 7 days) then controlled sodium content diet (2 %) (for 28 days) Cicila GT, et al., Mamm Genome 1999 Feb;10(2):112-6. body mass male 65 days 20 306.8 g 4.6 20.57 body weighing method 0 0 11779 145
SS.SR-(Cyp11b1)/Jr body weight controlled sodium content diet (1 %) (for 30 days) then controlled sodium content diet (0.2 %) (for 40 days) Cicila GT, et al., Mamm Genome 1997 Dec;8(12):896-902. body mass male 100 days 16 336.7 g 6.7 26.8 body weighing method 0 11786 146
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. body mass male 68 days-70 days 20 297.1 g 2.3 10.29 body weighing method 0 11811 147
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. body mass male 68 days-70 days 20 289.8 g 3.2 14.31 body weighing method 0 11817 147
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 27 days) Cicila GT, et al., Genomics 2001 Feb 15;72(1):51-60. body mass male 68 days-70 days 20 297.7 g 2.5 11.18 body weighing method 0 11823 147
iP/Iusm body weight control condition Alam I, et al., J Bone Miner Res. 2010 Jan 8. body mass male 180 days 8 543.0 g 10.25 29.0 body weighing method 0.0 0 12755 308
NP.P-(D4Rat119-D4Rat55)/Iusm body weight control condition Alam I, et al., J Bone Miner Res. 2010 Jan 8. body mass male 180 days 8 609.0 g 11.67 33.0 body weighing method 0.0 0 12756 308
SHR/N body weight control condition Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6. body mass male 84 days 14 441.0 g 26.0 97.28 body weighing method 0 13046 327
F344.GK-(D1Rat83-D1Rat376)/Swe body weight fasting (for 6 hours) Granhall C, et al., Genetics. 2006 Nov;174(3):1565-72. Epub 2006 Sep 1. body mass male 95 days 24 290.0 g 5.0 24.49 body weighing method 0 0 13108 330
F344.OLETF-(D1Rat166-D1Rat90)/Tj body weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. body mass male 245 days 9 483.1 g 6.8 20.4 body weighing method 0 12442 262
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 318.0 g 3.57 15.97 body weighing method 0 12484 266
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 308.0 g 1.68 7.51 body weighing method 0 12489 266
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 302.0 g 3.24 14.49 body weighing method 0 12490 266
SS.LEW-(D1Mco2-D1Rat49)/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 28 days) Saad Y, et al., Physiol Genomics 2001 Jan 19;4(3):201-14. body mass male 68 days-70 days 20 294.0 g 2.63 11.76 body weighing method 0 12493 266
BC/CpbU body weight controlled olive oil content diet (5 %) (for 28 days) and controlled cholesterol content diet (2 %) (for 28 days) Bonne AC, et al., Arterioscler Thromb Vasc Biol 2002 Dec 1;22(12):2072-9. body mass female 77 days 6 177.0 g 1.63 4.0 body weighing method 0 12606 271
SS.SR-(D3Mco24-D3Got130)/Jr body weight controlled sodium content diet (0.4 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 24 and 28 days) Lee SJ, et al., Genetics 2006 Dec;174(4):2203-13. body mass male 70 days-72 days 19 307.7 g 1.9 8.28 body weighing method 0 12297 237
ACI.FHH-(D3Wox2-D3Rat59)/Eur body weight control condition Van Dijk SJ, et al., Kidney Int. 2006 body mass male 168 days-175 days 12 314.0 g 3.0 10.39 body weighing method 0.0 0 11926 62
ACI/Eur body weight right nephrectomy Van Dijk SJ, et al., Kidney Int. 2006 body mass male 168 days-175 days 12 315.0 g 3.0 10.39 body weighing method 0 11930 62
SS.MNS-(D2Wox27-Adh1)/Ayd body weight controlled sodium content diet (2 %) (between 35 and 98 days) Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 body mass male 98 days 5 352.0 g 15.0 33.54 body weighing method 0 0 12032 226
SS.LEW-(D3Rat52-D3Rat130)/Ayd body weight controlled sodium content diet (2 %) (between 35 and 98 days) Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 body mass male 98 days 7 390.0 g 6.0 15.87 body weighing method 0 0 12037 226
SS.LEW-(D16Rat38-D16Chm66)/Ayd body weight controlled sodium content diet (2 %) (between 35 and 98 days) Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 body mass male 98 days 8 360.0 g 15.0 42.43 body weighing method 0 0 12064 226
SS.LEW-(D17Chm9-D17Rat97)/Ayd body weight controlled sodium content diet (2 %) (between 35 and 98 days) Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 body mass male 98 days 10 367.0 g 15.0 47.43 body weighing method 0 0 12071 226
SS.LEW-(D18Chm41-D18Rat92)/Ayd body weight controlled sodium content diet (2 %) (between 35 and 98 days) Duong C, et al., Mamm Genome 2006; 17(12): 1147-1161 body mass male 98 days 5 386.0 g 5.0 11.18 body weighing method 0 0 12076 226
SS/Jr body weight controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Mamm Genome. 2008 Jan 4 body mass male 64 days-68 days 20 340.0 g 5.26 23.52 body weighing method 0 0 12141 232
SS.MNS-(D10Mco62-D10Mco30)/Mco body weight controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Mamm Genome. 2008 Jan 4 body mass male 64 days-68 days 20 345.0 g 7.09 31.71 body weighing method 0 0 12146 232
SS.MNS-(D10Mco30-D10Got112)/Mco body weight controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Mamm Genome. 2008 Jan 4 body mass male 64 days-68 days 20 299.0 g 2.78 12.43 body weighing method 0 0 12148 232
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Toland EJ, et al., Mamm Genome. 2008 Mar;19(3):209-18. Epub 2008 Mar 7. body mass male 64 days-66 days 20 345.0 g 1.65 7.38 body weighing method 0 0 12865 313
F344/DuCrlCrlj body weight control condition Muramatsu Y, et al., Biochem Biophys Res Commun 2005 Jun 17;331(4):1270-6. body mass male 245 days 12 393.6 g 5.31 18.4 body weighing method 0 12431 262
LEW/OlaHsd body weight controlled olive oil content diet (5 %) (for 30 days) and controlled cholesterol content diet (2 %) (for 30 days) de Wolf ID, et al., Exp Biol Med (Maywood) 2002 Jul;227(7):529-34. body mass male 77 days 4 352.0 g 17.0 34.0 body weighing method 0 12514 267
WKY body weight controlled sodium content diet (0.4 %) (for 122 days) then controlled sodium content diet (1.4 %) (for 210 days) Inomata H, et al., Hypertens Res 2005 Mar;28(3):273-81. body mass male 360 days 4 318.0 g 6.65 13.3 body weighing method 0 0 12588 268
F344.GK-(D1Arb42a-D1Rat90)/Swe body weight control condition (for 95 days) Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. body mass male 95 days 11 27.0 g 6.0 19.9 body weighing method 0.0 0 11443 85
F344/DuCrlCrlj body weight fasting (for 16 hours) Moralejo DH, et al., Proc Assoc Am Physicians 1998 Nov-Dec;110(6):545-58 body mass male 210 days 10 374.1 g 8.0 25.3 body weighing method 0 11968 228
SS/Jr body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Hypertension. 2007 body mass male 64 days-66 days 0 310.0 g 2.38 body weighing method 0 11976 205
SS.LEW-(D10Mco84-D10Mco134)/Mco body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Saad Y, et al., Hypertension. 2007 body mass male 64 days-66 days 0 306.0 g 2.34 body weighing method 0 11978 205
F344.OLETF-(D8Rat54-D8Mgh17)/2Tj body weight fasting (for 16 hours) Kose H, et al., Mamm Genome 2002 Oct;13(10):558-62. body mass male 210 days 19 398.6 g 4.9 21.36 body weighing method 0 11997 230
SHR/Mol body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. body mass male 56 days 12 221.0 g 2.6 9.0 body weighing method 0 12928 323
SHR/Mol body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. body mass male 70 days 12 265.0 g 2.89 10.0 body weighing method 0 12929 323
SHR/Mol body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 Jun 29;284(5):1126-33. body mass female 70 days 12 171.0 g 2.02 7.0 body weighing method 0.0 0 12939 323
SS/Jr body weight controlled sodium content diet (2 %) (for 28 days) Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. body mass male 68 days-70 days 20 318.0 g 2.09 9.35 body weighing method 0 12947 305
SS.SHR-(D9Wox16-D9Rat76)/Mco body weight controlled sodium content diet (2 %) (for 28 days) Toland EJ, et al., J Hypertens. 2008 Nov;26(11):2134-41. body mass male 68 days-70 days 20 366.0 g 3.96 17.71 body weighing method 0 12953 305
LEW/Crlc body weight gain controlled sodium content diet (8 %) (between 8 and 10 days) Huang BS, et al., Hypertension. 2007 Apr 9;. body mass male 43 days-52 days 8 54.0 g 3.0 8.49 body weighing method 0 13315 344
DA/OlaHsd body weight running on inclined treadmill (10 m/min) (for 0.1 hours) Lee SJ, et al., Physiol Genomics 2005 Jul 20;. body mass male 105 days 4 270.1 g body weighing method 0.0 0 13336 345
HTG body weight control condition Ueno T, et al., Physiol Genomics 2004 Mar 12;17(1):38-47. body mass female 150 days-180 days 10 238.2 g 6.5 20.55 body weighing method 0 13152 120
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj body weight specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) Kose H, et al., Mamm Genome. 2007 Aug;18(8):609-15. Epub 2007 Aug 21. body mass male 211 days 7 368.7 g 8.7 23.02 body weighing method oral glucose 0 min 12791 311
SR/Jr body weight controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 28 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass male 63 days 10 243.0 g 5.5 17.39 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 12184 222
LEW/NCrl body weight controlled sodium content diet (0.2 %) (for 5 days) then controlled sodium content diet (8 %) (for 28 days) Garrett MR, et al., Genome Res 1998 Jul;8(7):711-23 body mass male 63 days 8 286.0 g 4.4 12.45 body weighing method 0 0 4 rats per cage, 2 SR/Jr 2 LEW/NCrl 12194 222
ACI/Eur body weight unilateral nephrectomy then controlled hydrogen ion content drinking water (2.4-2.8 pH) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 173 days-180 days 8 308.0 g 5.0 14.14 body weighing method 0.0 0 67678 751
ACI/SegHsd body weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. body mass male 900 days 12 null 419.6 g body weighing method 0 method not specified, assumed to be digital scale 13301 341
F344/Jcl body weight control condition Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. body mass male 900 days 8 null 350.7 g body weighing method 0 method not specified, assumed to be digital scale 13302 341
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur body weight controlled hydrogen ion content drinking water (2.4-2.8 pH) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 173 days-180 days 7 283.0 g 8.0 21.17 body weighing method 0.0 0 67500 751
ACI/Eur body weight controlled hydrogen ion content drinking water (2.4-2.8 pH) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 173 days-180 days 8 315.0 g 6.0 16.97 body weighing method 0.0 0 67499 751
SS.SHR-(D9Mco72-D9Mco109)/Mco body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (between 25 and 28 days) Kumarasamy S, et al., Hypertens Res. 2011 Dec;34(12):1263-70. doi: 10.1038/hr.2011.116. Epub 2011 Aug 4. body mass not specified 0 days 0 307.0 g 2.84 body weighing method 0.0 0 67530 749
SHR.BN-(D16Rat87-D16Mgh1)/Jk body weight controlled sodium content diet (1 %) (for 14 days) Aneas I, et al., Physiol Genomics. 2009 Mar 3;37(1):52-7. Epub 2009 Jan 6. body mass male 87 days 23 271.0 g 5.0 23.98 body weighing method 0 0 65437 306
SS/Jr body weight control condition Garrett MR, et al., J Am Soc Nephrol 2003 May;14(5):1175-87 body mass male 182 days-183 days 6 485.0 g 11.9 29.15 body weighing method 0 0 65446 104
ACI/N body weight control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 body mass both 70 days 220 202.4 g 0.68 10.1 body weighing method 0 0 66007 114
WN/N body weight control condition Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8 body mass both 70 days 220 256.0 g 0.53 7.8 body weighing method 0 0 66012 114
SS-Chr 19SHR/Rkb body weight controlled sodium content diet (0.2 %) (for 56 days) Wendt N, et al., J Hypertens. 2007 Jan;25(1):95-102. body mass male 98 days 20 355.0 g 8.0 35.78 body weighing method 0 0 66084 669
BN.GK-(D8Got302-D8Got130)/Ox body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass female 168 days 16 209.0 g 3.0 12.0 body weighing method 0.0 0 67314 66
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur body weight unilateral nephrectomy then controlled NG-nitroarginine methyl ester content in acidified drinking water (11-15 mg/kg/d) (for 126 days) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 173 days-180 days 9 284.0 g 6.0 18.0 body weighing method 0.0 0 67682 751
ACI/Eur body weight NG-nitroarginine methyl ester (50-150 mg/l) Van Dijk SJ, et al., Kidney Int. 2006 body mass male 168 days-175 days 12 319.0 g 5.0 17.32 body weighing method 0.0 0 67700 62
ACI.FHH-(D17Rat117-D17Arb5)(D17Rat180-D17Rat51)/Eur body weight controlled hydrogen ion content drinking water (2.4-2.8 pH) Van Dijk SJ, et al., Nephron Exp Nephrol 2005 Jun 20;101(2):e59-e66. body mass male 98 days 15 248.0 g 6.0 23.24 body weighing method 0.0 0 68033 751
DA/K body mass index (BMI) control condition Kovacs P, et al., Biochem Biophys Res Commun 2000 Mar 24;269(3):660-5. body mass not specified 224 days 12 0.62 g/cm2 0.01 0.04 body weighing method 0.0 0 69111 1123
BN/Cub body weight controlled sucrose content diet (for 7 days) Seda O, et al., Physiol Genomics. 2005 Apr 14;21(2):243-52. Epub 2005 Feb 22. body mass male 307 days 6 291.1 g 10.29 25.2 body weighing method 0.0 0 70208 1318
SHR/NHsdMco body weight control condition (for 140 days) Garrett MR, et al., Physiol Genomics. 2007 May 15;. body mass male 140 days 6 339.0 g 9.3 22.78 body weighing method 0.0 0 67973 834
DA/ZtmKini maximum body weight loss to initial body weight ratio myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. body mass male 103 days-131 days 11 14.4 % 2.47 8.2 body weighing method 0.0 intradermal injection 40 days from before p.i. CMO:0001400 68134 839
DA/ZtmKini maximum body weight loss to initial body weight ratio myelin oligodendrocyte glycoprotein (20 ug) Jagodic M, et al., Immunogenetics 2001 Jul;53(5):410-5. body mass male 103 days-131 days 12 1.0 % 0.78 2.7 body weighing method 0.0 intradermal injection 40 days from before p.i. 68712 839
ACI.FHH-(D1Rat384-D1Rat156)/Eur body weight unilateral nephrectomy van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. body mass not specified 168 days-175 days 12 305.0 g 8.0 27.71 body weighing method 0.0 unilateral nephrectomy 126 days 67900 832
ACI.FHH-(D1Rat384-D1Rat156)/Eur body weight specific pathogen-free condition van Dijk SJ, et al., Nephron Exp Nephrol. 2006;104(3):e96-e102. Epub 2006 Jul 12. body mass not specified 168 days-175 days 12 312.0 g 6.0 20.78 body weighing method 0.0 0 67904 832
E3/Ztm body weight gain spinal cord homogenate (10 mg) Bergsteinsdottir K, et al., J Immunol 2000 Feb 1;164(3):1564-8 body mass female 56 days-103 days 12 80.0 g 0.87 3.0 body weighing method 0.0 0 69956 1258
ACI.FHH-(D3Wox2-D3Rat59)/Eur body weight right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) Van Dijk SJ, et al., Kidney Int. 2006 body mass male 168 days-175 days 11 301.0 g 6.0 19.9 body weighing method 0.0 0 67705 62
ACI.FHH-(D1Rat298-D1Rat90)/Eur body weight right nephrectomy then NG-nitroarginine methyl ester (50-150 mg/l) Van Dijk SJ, et al., Kidney Int. 2006 body mass male 168 days-175 days 12 319.0 g 6.0 20.78 body weighing method 0.0 0 67706 62
DA/ZtmKini body weight control condition Stridh P, et al., PLoS One. 2010 Sep 15;5(9):e12716. body mass female 56 days-77 days 0 162.9 g 9.5 body weighing method 0.0 0 68120 837
COP.DA-(D3Rat233-D3Mgh14)/Mco body weight control condition Ways JA, et al., Physiol Genomics. 2006 Dec 19;. body mass not specified 105 days 18 252.6 g 4.6 19.52 body weighing method 0.0 0 68488 933
DA/Ztm maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 12 13.4 % 1.4 4.85 body weighing method 0.0 0 69798 1162
DA.PVG.1AV1-(D4Rat155-Spr) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 14 12.5 % 0.9 3.37 body weighing method 0.0 0 69800 1162
DA.PVG.1AV1-(D4Mgh17-D4Rat56) maximum body weight loss to initial body weight ratio type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass male 120 days-200 days 13 6.6 % 1.3 4.69 body weighing method 0.0 0 69803 1162
DA.PVG.1AV1-(D4Rat155-D4Rat84) maximum body weight loss to initial body weight ratio pristane (150 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 16 8.8 % 2.2 8.8 body weighing method 0.0 0 69805 1162
DA.PVG.1AV1-(D4Rat63-D4Rat203) maximum body weight loss to initial body weight ratio squalene (200 ul) Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9. body mass both 120 days-200 days 10 6.6 % 2.5 7.91 body weighing method 0.0 0 69808 1162
SS/JrHsdMcwi body weight controlled sodium content diet (4 %) (for 21 days) Mattson DL, et al., Am J Physiol Regul Integr Comp Physiol. 2013 Jan 30. body mass not specified 84 days 4 343.0 g 16.0 32.0 body weighing method 0.0 0 69287 1057
Crl:CD(SD) body weight standard diet then acetaminophen (500 mg/kg) (for 35 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 105 days 8 472.0 g 8.49 24.0 body weighing method 0.0 0 85532 1604
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) then acetaminophen (300 mg/kg) (for 98 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 168 days 8 447.0 g 16.62 47.0 body weighing method 0.0 0 85552 1604
Crl:CD(SD) body weight standard diet Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 105 days 19 481.0 g 11.7 51.0 body weighing method 0.0 0 85314 1604
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 126 days 19 401.0 g 4.82 21.0 body weighing method 0.0 0 85317 1604
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 14 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 84 days 8 321.0 g 7.78 22.0 body weighing method 0.0 0 85529 1604
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 56 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 126 days 8 400.0 g 7.78 22.0 body weighing method 0.0 0 85541 1604
Crl:CD(SD) body weight standard diet then acetaminophen (500 mg/kg) (for 98 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 168 days 8 564.0 g 15.2 43.0 body weighing method 0.0 0 85550 1604
Crl:CD(SD) body weight standard diet and restricted feeding (4 h) then acetaminophen (500 mg/kg) (for 98 days) Kondo K, et al., J Toxicol Sci. 2012;37(5):911-29. body mass male 168 days 8 440.0 g 9.19 26.0 body weighing method 0.0 0 85553 1604
BluHsd:LE body weight gain controlled in utero environment (for 9 days) and bisphenol A (25 ug/kg) (for 30 days) then maternal milk (for 21 days) then controlled fat content diet (21.2 %) (for 28 days) Nanjappa MK, et al., Toxicol Lett. 2014 Mar 21;225(3):479-87. doi: 10.1016/j.toxlet.2014.01.024. Epub 2014 Jan 26. body mass male 71 days-98 days 8 150.1 g 4.7 13.29 body weighing method 0.0 0 76163 1543
SD body weight acetaminophen (1000 mg/kg) (for 8 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 50 days-64 days 6 208.8 g body weighing method 0.0 0 84790 1602
SD body weight acetaminophen (1000 mg/kg) (for 15 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass male 57 days-71 days 6 231.9 g body weighing method 0.0 0 84791 1602
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 50 days-64 days 6 148.3 g body weighing method 0.0 0 84795 1602
SD body weight acetaminophen (1000 mg/kg) (for 22 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 64 days-78 days 6 160.7 g body weighing method 0.0 0 84822 1602
SD body weight acetaminophen (1000 mg/kg) (for 28 days) Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 164.5 g body weighing method 0.0 0 84823 1602
F344/NHsd body weight control condition Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. body mass male 579 days-945 days 9 424.8 g 14.5 43.5 body weighing method 0.0 0 84701 1599
F344/NHsd body weight control condition Mach J, et al., J Gerontol A Biol Sci Med Sci. 2013 Jul 17. body mass male 132 days-264 days 5 381.2 g 9.4 21.02 body weighing method 0.0 0 84708 1599
CrljJcl:SD body weight gestation (for 20 days) then controlled bisphenol A content drinking water (0.01 mg/l) (for 9 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 8 361.54 g 33.76 95.49 body weighing method 0.0 0 75907 1539
CrljJcl:SD body weight gestation (for 21 days) then controlled bisphenol A content drinking water (1 mg/l) (for 17 days) then lactation (for 7 days) Xu X, et al., Neurotoxicol Teratol. 2011 Jul-Aug;33(4):458-63. doi: 10.1016/j.ntt.2011.06.002. Epub 2011 Jun 17. body mass female 0 days 8 259.23 g 24.17 68.36 body weighing method 0.0 0 75918 1539
Hsd:WI body weight silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. body mass male 0 days 6 143.6 g 0.41 1.0 body weighing method 0.0 0 75954 1544
Hsd:WI body weight bisphenol A (125 mg/kg/d) (for 91 days) Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. body mass male 119 days-126 days 6 314.83 g 6.15 15.07 body weighing method 0.0 0 76042 1545
Hsd:WI body weight octylphenol (125 mg/kg/d) (for 91 days) Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. body mass male 119 days-126 days 6 326.67 g 14.98 36.69 body weighing method 0.0 0 76047 1545
Hsd:WI change in body weight to body weight ratio vehicle control condition (for 91 days) Yildiz N and Barlas N, Hum Exp Toxicol. 2013 Jul;32(7):675-86. doi: 10.1177/0960327112464796. body mass male 119 days-126 days 5 255.0 % 13.42 30.0 body weighing method 0.0 0 76065 1545
W-LeprfaNin body weight controlled retinyl palmitate content diet (26 mg/kg) (between 36 and 42 days) then fasting (for 12 hours) Tiruvalluru M, et al., Nutrition. 2013 Jan;29(1):298-304. doi: 10.1016/j.nut.2012.06.006. Epub 2012 Oct 2. body mass male 284 days 6 883.0 g 38.9 95.29 body weighing method 0.0 0 96722 1660
SD body weight control condition Venkatesan PS, et al., Biol Pharm Bull. 2014 Apr 5. body mass female 70 days-84 days 6 160.5 g body weighing method 0.0 0 84818 1602
SHR-Ndufc2em1Mcwi+/+ body weight controlled protein content diet (19.7 %) (for 28 days) and controlled potassium content diet (6.3 mg/g) (for 28 days) and controlled sodium content diet (3.7 mg/g) (for 28 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 70 days 10 235.0 g 4.74 15.0 body weighing method 0.0 0 97877 1938
PXO9/Cub body weight controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours) Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014. body mass male 127 days 9 245.0 g 6.2 18.6 body weighing method 0.0 0 97160 1858
SHR-Ndufc2em1Mcwi+/+ body weight controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 126 days 10 309.0 g 8.54 27.0 body weighing method 0.0 0 97879 1938
SHR-Ndufc2em1Mcwi-/+ body weight controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 126 days 17 308.0 g 5.09 21.0 body weighing method 0.0 0 97897 1938
SHR-Ndufc2em2Mcwi-/+ body weight controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 98 days 24 293.0 g 6.12 30.0 body weighing method 0.0 0 97904 1938
SHR/Bbb body weight controlled protein content diet (19.7 %) (for 56 days) and controlled potassium content diet (6.3 mg/g) (for 56 days) and controlled sodium content diet (3.7 mg/g) (for 56 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 98 days 18 260.0 g 3.77 16.0 body weighing method 0.0 0 97907 1938
SHR/Bbb body weight controlled protein content diet (19.7 %) (for 84 days) and controlled potassium content diet (6.3 mg/g) (for 84 days) and controlled sodium content diet (3.7 mg/g) (for 84 days) Rubattu S, et al., J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701. body mass not specified 126 days 18 289.0 g 1.89 8.0 body weighing method 0.0 0 97908 1938
PXO6-1/Cub body weight controlled sucrose content diet (70 % of calories) (between 0 and 168 hours) and controlled protein content diet (19.6 % of calories) (between 0 and 168 hours) and controlled fat content diet (10.4 % of calories) (between 0 and 168 hours) then fasting (between 0 and 16 hours) Hodulova M, et al., PLoS One. 2014 Oct 8;9(10):e109983. doi: 10.1371/journal.pone.0109983. eCollection 2014. body mass male 127 days 10 251.2 g 5.5 17.39 body weighing method 0.0 0 97162 1858
SS.LEW-(D1Rat200-D1Mco136)/Bj body weight controlled sodium content diet (0.3 %) (between 10 and 12 days) then controlled sodium content diet (2 %) (for 24 days) Mell B, et al., Hypertens Res. 2015 Jan;38(1):61-7. doi: 10.1038/hr.2014.134. Epub 2014 Sep 18. body mass male 73 days-75 days 10 331.0 g 5.0 15.81 body weighing method 0.0 0 96968 1778
WKY body weight 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 11 319.0 g 5.0 16.58 body weighing method 0.0 0 100394 2479
SS/Jr body weight controlled sodium chloride content diet (0.3 %) (for 21 days) then controlled sodium chloride content diet (8 %) (for 42 days) Sobajima M, et al., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2214-20. doi: 10.1152/ajpheart.00615.2010. Epub 2011 Mar 18. body mass not specified 84 days 5 332.0 g 22.36 50.0 body weighing method 0.0 0 103141 2787
SS-Plod1em1Mcwi-/- body weight controlled sodium content diet (0.4 %) (between 56 and 63 days) then controlled sodium content diet (4 %) (for 12 days) Flister MJ, et al., Genome Res. 2013 Dec;23(12):1996-2002. doi: 10.1101/gr.160283.113. Epub 2013 Sep 4. body mass male 60 days-69 days 0 298.0 g 6.0 body weighing method 0.0 0 98465 2059
FHH-Nr4a1m1Mcwi body weight control condition Westbrook L, et al., J Am Soc Nephrol. 2014 Nov;25(11):2499-510. doi: 10.1681/ASN.2013070786. Epub 2014 Apr 10. body mass male 168 days 6 352.0 g 14.0 34.29 body weighing method 0.0 0 99456 2318
WKY body weight control condition (for 0 hours) Cerutti C, et al., Physiol Genomics. 2006 Nov 27;27(3):295-308. doi: 10.1152/physiolgenomics.00318.2005. Epub 2006 Aug 1. body mass male 84 days 5 260.0 g 7.0 15.65 body weighing method 0.0 0 103476 2826
GK body weight control condition Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. body mass male 140 days 6 366.0 g 8.0 19.6 body weighing method 0.0 0 103488 2827
WKY/NCrl body weight salidroside (40 mg/kg) (for 28 days) Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57. body mass male 168 days 6 462.0 g 6.0 14.7 body weighing method 0.0 0 103491 2827
WF/Mol body weight gain vehicle control condition then sham surgical control condition (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 5 23.0 g 3.0 6.71 body weighing method 0.0 sham acf 7 days change from surgery weight 101343 2585
SS/JrHsd body weight control condition Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1. body mass female 0 days 0 235.0 g 3.6 body weighing method 0.0 0 102182 2681
SS/JrHsd body weight controlled sodium chloride content diet (4 %) (for 14 days) then sham surgical control condition then peanut oil (0.2 ml) (for 14 days) Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1. body mass female 0 days 0 235.0 g 13.0 body weighing method 0.0 0 102190 2681
SS/JrHsd body weight controlled sodium chloride content diet (4 %) (for 14 days) then bilateral ovariectomy then peanut oil (0.2 ml) (for 14 days) Zheng W, et al., Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1508-13. doi: 10.1152/ajpheart.01322.2007. Epub 2008 Feb 1. body mass female 0 days 0 297.0 g 5.1 body weighing method 0.0 0 102192 2681
LL/Mav body weight streptozotocin (100 mg/kg) Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. body mass male 112 days 18 331.0 g 3.0 12.73 body weighing method 0.0 0 102723 2721
LH/Mav body weight streptozotocin (75 mg/kg) Emonnot L, et al., J Hypertens. 2007 Feb;25(2):429-38. body mass male 112 days 14 388.0 g 5.0 18.71 body weighing method 0.0 0 102725 2721
Jcl:WI body weight standard diet Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. body mass male 84 days 8 432.0 g 10.25 29.0 body weighing method 0.0 0 103055 2785
SR body weight controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days) Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18. body mass male 84 days 6 352.0 g 8.16 20.0 body weighing method 0.0 0 103299 2803
WKY body weight controlled in utero environment (100 % of calories) (for 22 days) Riviere G, et al., Hypertension. 2005 Nov;46(5):1169-74. Epub 2005 Oct 3. body mass male 112 days 17 454.0 g 8.0 32.98 body weighing method 0.0 0 99075 2218
SD body weight in utero condition (for 7 days) and corn oil (for 7 days) Jiang JT, et al., Toxicology. 2015 Dec 2;338:77-85. doi: 10.1016/j.tox.2015.10.006. Epub 2015 Oct 26. body mass male 1 days 0 6.34 g 0.34 body weighing method 1.0 0 98736 2158
SS body weight controlled sodium content diet (6 %) (between 56 and 70 days) Kamei K, et al., Circ J. 2007 Mar;71(3):390-6. body mass male 98 days-132 days 7 417.0 g 31.75 84.0 body weighing method 0.0 0 103349 2804
SS-Nppbem2Mcwi+/+ body weight control condition (for 84 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 84 days 6 398.0 g 16.0 39.19 body weighing method 0.0 0 99547 2319
SS-Nppbem2Mcwi+/+ body weight control condition (for 168 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 168 days 5 438.0 g 21.0 46.96 body weighing method 0.0 0 99549 2319
SS-Nppbem2Mcwi-/- body weight control condition (for 168 days) Holditch SJ, et al., Hypertension. 2015 Jul;66(1):199-210. doi: 10.1161/HYPERTENSIONAHA.115.05610. Epub 2015 May 11. body mass male 168 days 5 425.0 g 22.0 49.19 body weighing method 0.0 0 99550 2319
SS/NEisSlc body weight controlled sodium chloride content diet (8 %) (for 21 days) then 0.9% sodium chloride solution (for 21 days) Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. body mass male 77 days 14 348.0 g 4.01 15.0 body weighing method 0.0 0 102454 2689
SS/NEisSlc body weight controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days) Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35. body mass male 77 days 10 344.0 g 8.22 26.0 body weighing method 0.0 0 102482 2690
WKY body weight left anterior descending coronary artery occlusion then furosemide Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. body mass male 42 days-56 days 20 225.0 g 3.0 13.42 body weighing method 0.0 lad occlusion 0 days 100268 2460
SD change in body weight unilateral nephrectomy (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 59.0 g 10.96 31.0 body weighing method 0.0 unx 28 days change from surgery weight 101609 2602
SD change in body weight unilateral nephrectomy (for 28 days) then spironolactone (5.56 mg/kg/d) (for 28 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 8 48.0 g 10.96 31.0 body weighing method 0.0 unx 28 days change from surgery weight 101610 2602
SD change in body weight unilateral nephrectomy (between 12 and 14 days) then enalapril (50 mg/l) (between 12 and 14 days) and losartan (180 mg/l) (between 12 and 14 days) Greene EL, et al., J Clin Invest. 1996 Aug 15;98(4):1063-8. body mass male 0 days 5 74.0 g 7.6 17.0 body weighing method 0.0 unx 13 days change from surgery weight 101541 2602
Crlj:WI body weight air oxygen content (5 %) (for 28 days) Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. body mass male 16 days 7 300.0 g 5.0 13.23 body weighing method 0.0 0 103000 2784
GK body weight air oxygen content (5 %) (for 28 days) Chen YC, et al., Am J Physiol Regul Integr Comp Physiol. 2016 Aug 1;311(2):R426-39. doi: 10.1152/ajpregu.00112.2016. Epub 2016 Jun 1. body mass male 16 days 7 333.0 g 6.0 15.87 body weighing method 0.0 0 103002 2784
SD body weight artificial aortocaval fistula (for 5 days) Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. body mass male 0 days 6 281.0 g 4.0 9.8 body weighing method 1.0 ACF 5 days 98775 2160
WKY body weight streptozotocin (60 mg/kg) then benazepril (10 mg/kg/d) then gene transfer of the murine angiotensin I converting enzyme 2 gene using an adenovirus vector (40000000000 null) Liu CX, etal., Mol Med. 2011 Jan-Feb;17(1-2):59-69. doi: 10.2119/molmed.2010.00111. Epub 2010 Sep 14. body mass male 156 days 10 286.6 g 21.95 69.41 body weighing method 0.0 0 99112 2219
SD body weight left nephrectomy (for 56 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (0.5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 7 386.0 g 7.0 18.52 body weighing method 0.0 unx 56 days 98934 2179
SD body weight left nephrectomy (for 70 days) then puromycin (100 mg/kg) then anti-transforming growth factor beta antibody (5 mg/kg) then puromycin (40 mg/kg) Ma LJ, et al., Kidney Int. 2004 Jan;65(1):106-15. body mass male 0 days 9 281.0 g 15.0 45.0 body weighing method 0.0 unx 70 days 98936 2179
F344/NSlc body weight control condition Kotoh J, et al., J Vet Med Sci. 2016 Aug 11. body mass male 175 days 8 412.03 g 8.93 25.26 body weighing method 0.0 0 98031 1978
SD body weight streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. body mass male 0 days 8 563.0 g 12.37 35.0 body weighing method 0.0 stz 154 days 99891 2358
SD body weight control condition Jung FF, etal., J Am Soc Nephrol. 1995 Feb;5(8):1573-80. body mass male 420 days-450 days 9 572.0 g 14.4 43.2 body weighing method 0.0 0 101215 2582
SS/JrHsd body weight controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. body mass female 112 days 6 350.5 g 11.3 27.68 body weighing method 0.0 ovx 63 days 102341 2686
SR/JrHsd body weight controlled sodium content diet (0.1 %) (for 112 days) then bilateral ovariectomy (between 56 and 63 days) and 17 beta-estradiol (5 mg) (between 56 and 63 days) Esqueda ME, et al., Hypertension. 2007 Oct;50(4):768-72. Epub 2007 Aug 13. body mass female 112 days 6 209.5 g 5.3 12.98 body weighing method 0.0 ovx 63 days 102345 2686
SS-Renem1Mcwi+/- body weight controlled sodium content diet (0.4 %) (for 49 days) Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. body mass male 70 days 9 321.0 g 11.14 33.42 body weighing method 0.0 0 98291 2038
SS-Renem1Mcwi+/+ body weight controlled sodium content diet (0.4 %) (for 49 days) Moreno C, et al., Hypertension. 2011 Mar;57(3):614-9. doi: 10.1161/HYPERTENSIONAHA.110.163840. Epub 2011 Jan 17. body mass female 70 days 8 204.5 g 3.31 9.36 body weighing method 0.0 0 98292 2038
MW body weight nephrectomy (for 28 days) then control condition Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. body mass male 0 days 8 250.0 g 3.0 8.49 body weighing method 0.0 5/6 nephrectomy 28 days 100983 2561
GK/MolTac body weight control condition Keller AC, et al., J Cardiovasc Pharmacol. 2015 Feb;65(2):137-47. doi: 10.1097/FJC.0000000000000170. body mass male 147 days 6 382.0 g 13.0 31.84 body weighing method 0.0 0 103981 2885
Crl:WI(WU) body weight abdominal aortic constriction then losartan (3 mg/kg/d) (for 14 days) and icatibant (0.4 mg/kg/d) (for 14 days) Goetz RM and Holtz J, Clin Sci (Lond). 1999 Aug;97(2):165-74. body mass male 91 days 10 322.0 g 7.0 22.14 body weighing method 0.0 aorta coarctation 35 days 100011 2398
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 11 249.0 g 11.0 36.48 body weighing method 0.0 PA IV 50mg/kg 15 days 100392 2479
WKY body weight puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 7 245.0 g 9.0 23.81 body weighing method 0.0 PA IV 50mg/kg 15 days 100428 2479
SR/Jr body weight controlled sodium chloride content diet (0.3 %) (for 35 days) Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404. body mass male 63 days 16 218.0 g 9.0 36.0 body weighing method 0.0 0 103234 2802
SR/Jr body weight controlled sodium chloride content diet (8 %) (for 35 days) Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404. body mass male 63 days 13 225.0 g 8.0 28.84 body weighing method 0.0 0 103235 2802
SS/Jr body weight controlled sodium chloride content diet (0.3 %) (for 35 days) Vokurkov? M, et al., Hypertens Res. 2003 May;26(5):397-404. body mass male 63 days 15 271.0 g 10.0 38.73 body weighing method 0.0 0 103236 2802
SS-Leprem2Mcwi body weight control condition McPherson KC, et al., Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F793-F804. doi: 10.1152/ajprenal.00590.2015. Epub 2016 Jul 27. body mass male 126 days 19 528.0 g 15.0 65.38 body weighing method 0.0 0 100070 2418
WF/Mol body weight gain vehicle control condition then artificial aortocaval fistula (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 7 -5.0 g 2.0 5.29 body weighing method 0.0 acf 4 days change from surgery weight 101338 2585
SS.ZUC-Leprfa-/-/Slc body weight bilateral ovariectomy (for 42 days) then vehicle control condition (for 35 days) Murase T, et al., Hypertension. 2012 Mar;59(3):694-704. doi: 10.1161/HYPERTENSIONAHA.111.180976. Epub 2012 Jan 23. body mass female 91 days 8 393.0 g 6.0 16.97 body weighing method 0.0 ovariectomy 42 days 101663 2622
WKY body weight controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. body mass male 0 days 9 395.0 g 7.0 21.0 body weighing method 0.0 PA IV 50mg/kg 490 days 100435 2479
SD body weight sham surgical control condition (for 140 days) Lax CJ, et al., Clin Exp Pharmacol Physiol. 2004 Aug;31(8):512-7. body mass male 189 days 6 532.2 g 20.4 49.97 body weighing method 0.0 sham lad occlusion 140 days 101078 2564
WF/Mol body weight controlled ramipril content drinking water (3 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 5 186.0 g 1.0 2.24 body weighing method 0.0 sham acf 7 days 101305 2585
WF/Mol body weight controlled losartan content drinking water (10 mg/kg/d) (for 3 days) then sham surgical control condition (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 6 190.0 g 5.0 12.25 body weighing method 0.0 sham acf 2 days 101311 2585
WF/Mol body weight vehicle control condition then sham surgical control condition (for 2 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 6 200.0 g 2.0 4.9 body weighing method 0.0 2 days 101313 2585
WF/Mol body weight controlled losartan content drinking water (10 mg/kg/d) (for 8 days) then sham surgical control condition (for 7 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 6 204.0 g 2.0 4.9 body weighing method 0.0 sham acf 7 days 101319 2585
WF/Mol body weight gain controlled ramipril content drinking water (3 mg/kg/d) (for 5 days) then artificial aortocaval fistula (for 4 days) Wahlander H, et al., Acta Physiol Scand. 1999 Feb;165(2):143-54. body mass male 0 days 7 -4.0 g 2.0 5.29 body weighing method 0.0 acf 4 days change